The Pacific Mesothelioma Center (PMC) announced the issuance of a U.S. patent for their mesenchymal stem research program. The patent’s inventors Dr. Raymond Wong and Dr. Robert B. Cameron, Scientific Advisor at PMC, Director of the UCLA ...

A new study compiles and provides the latest evidence of the magnitude of asbestos-related diseases in order to present the best data for prevention and regulation. The study finds that asbestos-related deaths are indeed increasing worldwide while ...

The Pacific Mesothelioma Center (PMC), a division of the Pacific Heart, Lung & Blood Institute (PHLBI), is pleased to announce a generous donation from Roger G. Worthington, of the law office Worthington & Caron P.C. to purchase a ...

A new German study published in the European Respiratory Journal sought to determine if the fiber burden in the lungs of persons exposed to asbestos decreased over time. Researchers found that the passage of time from a person’s last exposure ...

A study conducted by a team of researchers from the University of Maryland Medical System, the University of Maryland School of Medicine, the Penn-Presbyterian Medical Center, the University of Pennsylvania and the Hospital of the University of ...

A new study published in the American Journal of Surgical Pathology highlights the value between tumor grading in peritoneal mesothelioma and prognosis. Tumor grade is different from mesothelioma tumor stage, which refers to the size or reach of the ...

A team of cancer specialists from Hungary, Austria, Australia, and Switzerland conducted a recent study and believe they have found a new and helpful malignant pleural mesothelioma biomarker. The specialists recently published their findings in the ...

According to a new report, pathologists from France and Canada believe they have been able to identify two test that would help distinguish between malignant mesothelioma and a benign growth on the mesothelial membrane. If these tests do work, it ...

A new study is using immunotherapy with live bacterium along with chemotherapy to help treat malignant pleural mesothelioma. The testing shows over 90% disease control and 59% response rate. The trial was presented yesterday in Geneva, Switzerland at ...

At Worthington & Caron, we know that patients diagnosed with mesothelioma are facing the most difficult times of their lives. They may have countless questions regarding what their medical and legal options are. While many people are wary of ...

Pacific Mesothelioma Center’s 4 th Annual Walk/Hike for Meso took place this past Sunday, September 27, as part of Mesothelioma Awareness Weekend. The hike once again took place at the iconic old Hollywood saloon town of Paramount Ranch in ...

Harleys, Triumphs, BMWs, and at least one Honda were lined up, revved up and raring to head out from Glendale Harley Davidson on Sunday, July 26. In prior years, the route had taken riders up Pacific Coast Highway to Malibu. This year’s ...

Science Daily reported on two recently published studies which both focus on therapies for mesothelioma that target the protein p53 within the body. P53 is responsible for regulating cell growth and the repair of damaged cells, but becomes inactive ...